Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.

Forsberg L, Navér L, Gustafsson LL, Wide K.

PLoS One. 2014 Nov 3;9(11):e111327. doi: 10.1371/journal.pone.0111327. eCollection 2014.

2.

Neonatal toxicity following maternal citalopram treatment.

Eleftheriou G, Butera R, Cotti Cottini F, Bonati M, Farina M.

Fetal Pediatr Pathol. 2013 Oct;32(5):362-6. doi: 10.3109/15513815.2013.768743. Epub 2013 Feb 25.

PMID:
23438790
3.

Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk.

Müller MJ, Preuß C, Paul T, Streit F, Brandhorst G, Seeliger S.

Breastfeed Med. 2013 Jun;8(3):327-9. doi: 10.1089/bfm.2012.0084. Epub 2012 Dec 18.

PMID:
23249132
4.

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.

Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.

PMID:
23128923
5.

Prenatal exposure to antidepressants: how safe are they?

Steiner M.

Am J Psychiatry. 2012 Nov;169(11):1130-2. doi: 10.1176/appi.ajp.2012.12081126. No abstract available.

PMID:
23128917
6.

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:45-52. doi: 10.1111/j.1360-0443.2012.04038.x.

7.

Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.

McLemore GL, Lewis T, Jones CH, Gauda EB.

Semin Fetal Neonatal Med. 2013 Feb;18(1):35-41. doi: 10.1016/j.siny.2012.09.002. Epub 2012 Oct 9. Review.

8.

Antidepressant drug exposure during pregnancy. CZTIS small prospective study.

Manakova E, Hubickova L.

Neuro Endocrinol Lett. 2011;32 Suppl 1:53-6.

PMID:
22167208
9.

The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.

Wachman EM, Newby PK, Vreeland J, Byun J, Bonganzi A, Bauchner H, Philipp BL.

J Addict Med. 2011 Dec;5(4):293-9. doi: 10.1097/ADM.0b013e3182266a3a.

PMID:
21857233
10.

Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Frankenthal D, Merlob P, Diamond G, Sirota L, Levinson-Castiel R, Linder N, Stahl B, Inbar D.

J Perinatol. 2011 Sep;31(9):615-20. doi: 10.1038/jp.2010.211. Epub 2011 Feb 10.

PMID:
21311497
11.

SSRI treatment during pregnancy: are we asking the right questions?

Wisner KL.

Depress Anxiety. 2010 Aug;27(8):695-8. doi: 10.1002/da.20729. No abstract available.

PMID:
20694964
13.

Prenatal depression and selective serotonin reuptake inhibitors.

Field T.

Int J Neurosci. 2010 Mar;120(3):163-7. doi: 10.3109/00207450802338697. Review.

PMID:
20374082
14.

Infant autonomic functioning and neonatal abstinence syndrome.

Jansson LM, Dipietro JA, Elko A, Velez M.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):198-204. doi: 10.1016/j.drugalcdep.2010.01.004. Epub 2010 Mar 1.

15.

Paroxetine and neonatal withdrawal syndrome.

Pogliani L, Schneider L, Dilillo D, Penagini F, Zuccotti GV.

BMJ Case Rep. 2010 Apr 29;2010. pii: bcr1220092528. doi: 10.1136/bcr.12.2009.2528.

16.

Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.

Koren G, Finkelstein Y, Matsui D, Berkovich M.

J Obstet Gynaecol Can. 2009 Apr;31(4):348-50. No abstract available.

PMID:
19497154
17.

Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.

Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, Kok CH, Coenen A, Forman T.

Pharmacopsychiatry. 2009 May;42(3):95-100. doi: 10.1055/s-0028-1103296. Epub 2009 May 18.

PMID:
19452377
18.

Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome.

Jordan AE, Jackson GL, Deardorff D, Shivakumar G, McIntire DD, Dashe JS.

J Matern Fetal Neonatal Med. 2008 Oct;21(10):745-51. doi: 10.1080/14767050802255488.

PMID:
19012191
19.

Prolonged neonatal complications after in utero exposure to fluoxetine.

Alehan F, Saygi S, Tarcan A, Gürakan B.

J Matern Fetal Neonatal Med. 2008 Dec;21(12):921-3. doi: 10.1080/14767050802266899.

PMID:
18985556
20.

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Merlob P.

Isr J Psychiatry Relat Sci. 2008;45(2):107-13. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk